Skip to main content
Log in

Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to elucidate the clinical features and symptoms of IgG4-related ophthalmic disease (IgG4-ROD).

Study design

Retrospective, multicenter study.

Methods

The medical charts of 378 patients with IgG4-ROD diagnosed at 9 hospitals in Japan were reviewed. The demographic profiles, clinical findings, and ocular symptoms of the patients were analyzed.

Results

On the basis of the diagnostic criteria for IgG4-ROD, the diagnosis was definite in 261 patients (69%), probable in 45 patients (12%), and possible in 72 patients (19%). The patients’ mean age at the time of diagnosis was 60.6 ± 13.9 years; 195 (52%) were male. The mean IgG4 serum level at the time of the initial diagnosis was 578.9 mg/dL. Imaging studies showed pathologic lesions as follows: lesions in the lacrimal glands (86%), extraocular muscles (21%), trigeminal nerve (20%), and eyelids (12%); isolated orbital mass (11%); diffuse orbital lesion (8%); lesion in the perioptic nerve (8%); and lesion in the sclera (1%). The ophthalmic symptoms included dry eye (22%), diplopia (20%), decreased vision (8%), and visual field defects (5%). IgG4-ROD with extraocular lesions was observed in 182 patients (48%).

Conclusion

Although the lacrimal glands are well known to be the major pathologic site of IgG4-ROD, various ocular tissues can be affected and cause ophthalmic symptoms including visual loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.

    Article  CAS  Google Scholar 

  2. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.

    Article  CAS  Google Scholar 

  3. Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire J-F, et al. The 2019 American college of rheumatology/european league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77–87.

    Article  CAS  Google Scholar 

  4. Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al. The 2020 revised diagnostic criteria for IgG4-related disease. Mod Rheumatol. 2020;4:1–14.

    Google Scholar 

  5. Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.

    Article  CAS  Google Scholar 

  6. Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol. 2014;252:531–8.

    Article  CAS  Google Scholar 

  7. Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1–7.

    Article  CAS  Google Scholar 

  8. Uchida K, Masamune A, Shimosegawa T, Okazaki K. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol. 2012;2012: 358371. https://doi.org/10.1155/2012/358371.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Japanese Study Group of IgG4-Related Ophthalmic Disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57:573–9.

    Article  Google Scholar 

  10. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.

    Article  Google Scholar 

  11. Kashii S. IgG4-related disease: a neuro-ophthalmological perspective. J Neuroophthalmol. 2014;34:400–7.

    Article  Google Scholar 

  12. Li J, Zhang Y, Zhou H, Wang L, Wang Z, Li H. Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease. BMC Med Imaging. 2019;19:49.

    Article  Google Scholar 

  13. Hong JW, Kang S, Song MK, Ahn CJ, Sa HS. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2018;102:1591–5.

    Article  Google Scholar 

  14. Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, et al. Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series. Medicine. 2017;96: e6205. https://doi.org/10.1097/md.0000000000006205.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019;78:406–12.

    Article  CAS  Google Scholar 

  16. Kawa S, Skold M, Ramsden DB, Parker A, Harding SJ. Serum IgG4 concentration in IgG4-related disease. Clin Lab. 2017;63:1323–37.

    Article  CAS  Google Scholar 

  17. Woo YJ, Kim JW, Yoon JS. Clinical implications of serum IgG4 levels in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2017;101:256–60.

    PubMed  Google Scholar 

  18. Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine. 2016;95:e4002-e. https://doi.org/10.1097/MD.0000000000004002.

    Article  CAS  Google Scholar 

  19. Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719–24.

    Article  CAS  Google Scholar 

  20. Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Sci Rep. 2018;8:10262. https://doi.org/10.1038/s41598-018-28405-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Andrew NH, Gajdatsy A, Selva D. Intraorbital corticosteroid injection for the treatment of IgG4-related ophthalmic disease. Br J Ophthalmol. 2016;100:644–7.

    Article  Google Scholar 

  22. Ominato J, Oyama T, Cho H, Shiozaki N, Umezu H, Takizawa J, et al. The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study. BMJ Open Ophthalmol. 2019;4: e000295. https://doi.org/10.1136/bmjophth-2019-000295.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Japanese Ministry of Health, Labor and Welfare Research Program on Rare and Intractable Diseases, grant number JPMH20FC1040.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Goto.

Ethics declarations

Conflict of interest

H. Goto, None; S. Ueda, None; R. Nemoto, None; K. Ohshima, None; Y. Sogabe, None; K. Kitagawa, None; Y. Ogawa, None; T. Oyama, None; M. Furuta, None; A. Azumi, None; M. Takahira, None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Hiroshi Goto

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goto, H., Ueda, Si., Nemoto, R. et al. Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study. Jpn J Ophthalmol 65, 651–656 (2021). https://doi.org/10.1007/s10384-021-00847-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-021-00847-3

Keywords

Navigation